Three-Pronged attack on tough breast cancer: radiation, immunotherapy, and chemo tested in major trial
NCT ID NCT06627712
Summary
This large, late-stage trial is testing a new combination treatment for early-stage triple-negative breast cancer (TNBC), a type that is harder to treat. It combines a short, intense course of radiation (SBRT) with immunotherapy and standard chemotherapy before surgery. The goal is to see if this three-part approach can more effectively eliminate cancer cells and improve outcomes for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
RECRUITINGSichuan, Chengdu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.